- Home
- MNY vs PULM Comparison
MNY vs PULM Comparison
Compare MNY & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- PULM
- Stock Information
- Founded
- MNY 2014
- PULM 2003
- Country
- MNY Singapore
- PULM United States
- Employees
- MNY 286
- PULM N/A
- Industry
- MNY
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- PULM Health Care
- Exchange
- MNY Nasdaq
- PULM Nasdaq
- Market Cap
- MNY 43.9M
- PULM 33.2M
- IPO Year
- MNY N/A
- PULM N/A
- Fundamental
- Price
- MNY $1.50
- PULM $6.41
- Analyst Decision
- MNY Strong Buy
- PULM
- Analyst Count
- MNY 1
- PULM 0
- Target Price
- MNY $4.00
- PULM N/A
- AVG Volume (30 Days)
- MNY 517.5K
- PULM 57.7K
- Earning Date
- MNY 06-13-2025
- PULM 08-12-2025
- Dividend Yield
- MNY N/A
- PULM N/A
- EPS Growth
- MNY N/A
- PULM N/A
- EPS
- MNY N/A
- PULM N/A
- Revenue
- MNY $71,649,746.00
- PULM $1,921,000.00
- Revenue This Year
- MNY $16.97
- PULM N/A
- Revenue Next Year
- MNY $19.35
- PULM $134.88
- P/E Ratio
- MNY N/A
- PULM N/A
- Revenue Growth
- MNY N/A
- PULM N/A
- 52 Week Low
- MNY $0.55
- PULM $1.78
- 52 Week High
- MNY $1.88
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- MNY 75.86
- PULM 37.18
- Support Level
- MNY $0.99
- PULM $6.28
- Resistance Level
- MNY $1.10
- PULM $6.83
- Average True Range (ATR)
- MNY 0.18
- PULM 0.35
- MACD
- MNY 0.06
- PULM -0.07
- Stochastic Oscillator
- MNY 68.85
- PULM 0.00
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).